U.S. Marine and Shipping Stock News

In the first quarter of 2026, Blue Owl Capital Inc. reported higher year-over-year revenue of US$753.81 million and net income of US$15.54 million, completed a share repurchase of 5,409,281 shares for US$78.58 million, and declared a quarterly dividend of US$0.23 per share payable on May 27, 2026. An additional catalyst for investor attention was Blue Owl’s realization of a very large gain from selling part of its SpaceX stake, underscoring how realized profits from private investments can...

Market context and recent price performance Autoliv (ALV) has drawn attention after recent trading, with the stock closing at $114.67 and showing mixed returns, including a 1 day decline of 1.29% and a modest pullback over the past week. Despite shorter term softness, the stock shows a gain over the past month, alongside a decline over the past 3 months and year to date. This gives investors a split picture of recent momentum. See our latest analysis for Autoliv. For context, Autoliv’s recent...

X-Energy stock reaction and recent price moves X-Energy (XE) stock recently drew attention after a 2.5% decline in the latest session, extending a 17.3% drop over the past week while remaining slightly positive year to date at 1.9%. See our latest analysis for X-Energy. At a share price of $29.76, X-Energy’s recent 2.5% one-day share price decline and 17.3% seven-day share price drop contrast with its modest 1.9% year-to-date share price return. This suggests that momentum has recently...

Hilton Grand Vacations recently reported past first-quarter 2026 results, with sales rising to US$837 million, total revenue reaching US$1.29 billion, and net income improving to US$66 million from a prior-year loss, translating into earnings of US$0.79 per diluted share from continuing operations. The company’s strong earnings beat, higher margins, and raised full-year guidance were underpinned by robust real estate and financing performance, growing new-buyer sales, and the move to fully...

Indivior Pharmaceuticals (INDV) is back on investors' radars after a busy stretch that combined strong Q1 2026 results, a raised full year revenue outlook, and a fresh accelerated share repurchase plan. See our latest analysis for Indivior Pharmaceuticals. The recent Q1 beat, raised 2026 guidance, and the new accelerated share repurchase agreement have all coincided with strong momentum, with a 27.93% 1 month share price return and a very large 1 year total shareholder return that far...

Lindblad Expeditions Holdings, Inc. reported its Q1 2026 results and hosted its earnings call on May 5, 2026, after previously signaling these events for that date. The update builds on momentum in expedition cruising, partnerships with Disney and National Geographic, and expansion of land-based experiences that are reshaping Lindblad’s business mix. We’ll now examine how Q1 results and continued strength in Disney and National Geographic partnerships may influence Lindblad’s investment...

Allegiant Travel Company recently reported first-quarter 2026 results showing revenue of US$732.43 million and net income of US$42.48 million, with basic earnings per share from continuing operations of US$2.30, all higher than a year earlier despite rising fuel costs and lower system capacity. The company also delivered a record 14.9% adjusted operating margin and strong unit revenue growth while maintaining US$1.20 billions in liquidity, highlighting how its focus on peak-period flying,...

Alphatec Holdings, Inc. recently confirmed it would report Q1 2026 results after the market close on May 5, 2026, followed by an earnings call, while also preparing for its June 10, 2026 Annual Meeting where shareholders will vote on director elections, auditor ratification, and new equity plans. The company is highlighting a pay-for-performance compensation approach and expanded equity incentives at a time when investors are closely watching how ongoing revenue growth interacts with...

Event overview and why Global Net Lease is on investors’ radar Global Net Lease (GNL) has drawn investor attention after recent share price pressure, with the stock down around 4% over the past week and 3% over the past month, raising questions about how its fundamentals stack up. See our latest analysis for Global Net Lease. Despite recent share price pressure, Global Net Lease still shows stronger longer term momentum, with a 1 year total shareholder return of 34.66% compared with a year to...

Damora Therapeutics stock snapshot Damora Therapeutics (DMRA) has drawn investor attention after recent share price moves, with the stock closing at US$25.93 and showing mixed return patterns across the past week, month, past 3 months and year to date. See our latest analysis for Damora Therapeutics. The recent 1-day and 30-day share price returns of 2.25% and 3.35% respectively come on top of an 18.84% year to date share price return. The 1-year total shareholder return is around 7.5x, set...

Goldman Sachs addition puts Futu in focus Goldman Sachs has added Futu Holdings (FUTU) to its APAC Conviction List, highlighting the brokerage platform as a potential beneficiary of an improving Hong Kong IPO market and broader capital market trends. See our latest analysis for Futu Holdings. At a share price of US$156.04, Futu has a 30 day share price return of 11.33%, while the year to date share price return of 12.56% decline contrasts with a very large 3 year total shareholder return of...

Leadership shift puts Power Integrations stock in focus Power Integrations (POWI) has appointed veteran semiconductor sales executive Michael Balow as Senior Vice President of Worldwide Sales, drawing fresh attention to how new leadership might influence growth plans in key end markets. See our latest analysis for Power Integrations. The leadership announcement comes after a strong run in the stock, with a 30 day share price return of 39.11% and a year to date share price return of 95.31%,...

Lufax Holding (NYSE:LU) is back in focus after securities class action lawsuits followed its removal of auditor PwC. The auditor had questioned undisclosed related party transactions and prior audit opinions, putting governance and transparency under scrutiny. See our latest analysis for Lufax Holding. The recent lawsuits and auditor concerns have come after a long weak patch for investors, with a 30 day share price return of 5.91% offering only a short break. This followed a 90 day share...

In late April 2026, Benchmark Electronics reported first-quarter 2026 results showing sales of US$677.28 million and net income of US$13.02 million, while issuing second-quarter revenue guidance of US$700 million to US$740 million. The company also raised its full-year 2026 revenue growth outlook to 9%–10%, underscoring management’s confidence in momentum across medical, semiconductor capital equipment, and advanced computing and communications end markets. We’ll now consider how the...

PPL Corporation is scheduled to report its March 2026 quarter earnings on May 8, 2026, with analysts previously expecting a year-over-year increase and a positive Earnings ESP, while its Kentucky utilities are working with X-energy to evaluate Xe-100 small modular nuclear reactors as a potential clean, reliable power source. This combination of anticipated earnings strength and early-stage nuclear collaboration underscores how PPL is increasingly aligning its regulated utility footprint with...

Comfort Systems USA stock snapshot after recent move Comfort Systems USA (FIX) has attracted fresh attention after recent trading, with the stock showing strong multi period returns and a market value of about US$65.6b. That performance puts the company firmly on many investors’ watchlists. See our latest analysis for Comfort Systems USA. The recent 1-day share price return of 1.34% and 7-day return of 5.46% sit on top of a much stronger trend, with a 30-day share price return of 33.50% and a...

Edesa Biotech, Inc. ( NASDAQ:EDSA ) insiders who purchased shares in the last 12 months were richly rewarded last week...

Syndax Pharmaceuticals, Inc. ( NASDAQ:SNDX ) shareholders are probably feeling a little disappointed, since its shares...

We feel now is a pretty good time to analyse AmpliTech Group, Inc.'s ( NASDAQ:AMPG ) business as it appears the company...

While L.B. Foster Company ( NASDAQ:FSTR ) shareholders have had a good week with the stock up 15%, insiders can't say...

RB Global (RBA) has put fresh numbers on the table, reporting first quarter 2026 revenue of US$1,234.6 million and net income of US$135.5 million, both higher than the figures reported a year earlier. See our latest analysis for RB Global. RB Global’s recent earnings and governance updates have come against a mixed trading backdrop, with a 6.78% 1 month share price return but a 90 day share price decline of 8.42%. At the same time, the 3 year total shareholder return of 91.56% points to...

SiTime (SITM) has put timing technology back in the spotlight with its Elite 2 Super-TCXO launch, a chip aimed at tightening time synchronization in AI data centers and tackling GPU efficiency issues. See our latest analysis for SiTime. The Elite 2 Super-TCXO announcement comes after a period of strong momentum, with a 30 day share price return of 62.71% and a 1 year total shareholder return of 241.67%. This suggests that expectations and perceived risk have shifted meaningfully. If you are...

UFP Technologies has reported its first-quarter 2026 results, with sales rising to US$154.2 million and net income edging up to US$17.5 million, alongside slightly higher basic and diluted earnings per share versus a year earlier. Beneath these headline figures, growth in medical sales, a pullback in non-medical revenue, and new Dominican Republic facilities highlight the company’s sharpening focus on MedTech and capacity to support areas such as robotic surgery and safe patient...

TransMedics Group (TMDX) has drawn fresh attention after agreeing to invest in Germany based PAD Aviation to build a dedicated organ transplant logistics network in Europe, extending its Organ Care System reach. See our latest analysis for TransMedics Group. The stock has recently given back ground, with a 1 week share price return of a 10.21% decline and a 3 month share price return of a 28.47% decline. This comes even as product launches in Canada and progress on organ preservation trials...